When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HRTX - Heron's Zynrelef OK'd in Europe for post-op pain
Heron Therapeutics Inc.
As expected, the European Commission approves Heron Therapeutics' ([[HRTX]] +0.9%) Zynrelef (formerly HTX-011), a fixed-dose combination of local anesthetic bupivacaine and nonsteroidal anti-inflammatory med meloxicam, for the treatment of postoperative pain from small-to-medium-sized surgical wounds in adults.Two months ago, the advisory group CHMP adopted a positive opinion backing approval.